BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kryczka J, Kryczka J, Czarnecka-Chrebelska KH, Brzeziańska-Lasota E. Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy. Int J Mol Sci 2021;22:8885. [PMID: 34445588 DOI: 10.3390/ijms22168885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu P, So K, Chen H, Lin Q, Xu M, Lin Y. A monoclonal antibody against basic fibroblast growth factor attenuates cisplatin resistance in lung cancer by suppressing the epithelial-mesenchymal transition. Int J Immunopathol Pharmacol 2022;36:3946320221105134. [PMID: 35649742 DOI: 10.1177/03946320221105134] [Reference Citation Analysis]
2 Özdemir A, Ciftci H, Sever B, Tateishi H, Otsuka M, Fujita M, Altıntop MD. A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy. Molecules 2022;27:485. [PMID: 35056800 DOI: 10.3390/molecules27020485] [Reference Citation Analysis]
3 Franzi S, Mattioni G, Rijavec E, Croci GA, Tosi D. Neoadjuvant Chemo-Immunotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Review of the Literature. JCM 2022;11:2629. [DOI: 10.3390/jcm11092629] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yang Q, Zhai X, Lv Y. A Bibliometric Analysis of Triptolide and the Recent Advances in Treating Non–Small Cell Lung Cancer. Front Pharmacol 2022;13:878726. [DOI: 10.3389/fphar.2022.878726] [Reference Citation Analysis]
5 Liu XY, Zhang Q, Guo J, Zhang P, Liu H, Tian ZB, Zhang CP, Li XY. The Role of Circular RNAs in the Drug Resistance of Cancers. Front Oncol 2021;11:790589. [PMID: 35070998 DOI: 10.3389/fonc.2021.790589] [Reference Citation Analysis]
6 Galé A, Hofmann L, Lüdi N, Hungerbühler MN, Kempf C, Heverhagen JT, von Tengg-Kobligk H, Broekmann P, Ruprecht N. Beyond Single-Cell Analysis of Metallodrugs by ICP-MS: Targeting Cellular Substructures. Int J Mol Sci 2021;22:9468. [PMID: 34502377 DOI: 10.3390/ijms22179468] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Khalaji A, Haddad S, Yazdani Y, Moslemi M, Alizadeh L, Baradaran B. A bioinformatics-based study on the Cisplatin-resistant lung cancer cells; what are the orchestrators of this phenom? Gene 2022;834:146668. [PMID: 35690284 DOI: 10.1016/j.gene.2022.146668] [Reference Citation Analysis]
8 Lai TC, Lee YL, Lee WJ, Hung WY, Cheng GZ, Chen JQ, Hsiao M, Chien MH, Chang JH. Synergistic Tumor Inhibition via Energy Elimination by Repurposing Penfluridol and 2-Deoxy-D-Glucose in Lung Cancer. Cancers (Basel) 2022;14:2750. [PMID: 35681729 DOI: 10.3390/cancers14112750] [Reference Citation Analysis]